The predictive value of interleukin-8 (IL-8) in hospitalised patients with fever and chemotherapy-induced neutropenia

European Journal of Cancer

Volumn 45, Issue 4, 2009, Pages 596-600

  Tromp, Yvonne H ^a   Daenen, Simon M G J ^a   Sluiter, Wim J ^a   Vellenga, Edo ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Interleukin 8; Neutropenic fever; Predictive value

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 8; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA; COLITIS; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FEMALE; FEVER; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PYREXIA IDIOPATHICA; SINUSITIS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FEVER OF UNKNOWN ORIGIN; HOSPITALIZATION; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 60149107546     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.10.041     Document Type: Article

References (13)

1. Blijlevens N.M.A., Donnelly J.P., and de Pauw B.E. Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy. Clin Microbiol Infect 7 Suppl. 4 (2001) 47-52
2. Maschmeyer G., and Haas A. The epidemiology and treatment of infections in cancer patients. Int J Antimicrob Agents 31 (2008) 193-197
3. Klastersky J., Ameye L., Maertens J., et al. Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 30 Suppl. 1 (2007) S51-S59
4. Ramzi J., Mohamed Z., Yosr B., et al. Predictive factors of septic shock and mortality in neutropenic patients. Hematology 12 (2007) 543-548
5. Toussaint E., Bahel-Ball E., Vekemans M., et al. Causes of fever in cancer patients (prospective study over 477 episodes). Support Care Cancer 14 (2006) 763-769
6. Gençer S., Salepçi T., and Ozer S. Evaluation of infectious etiology and prognostic risk factors of febrile episodes in neutropenic cancer patients. J Infect 47 (2003) 65-72
7. Jagarlamudi R., Kumar L., Kochupillai V., Kapil A., Banerjee U., and Thulkar S. Infections in acute leukemia: an analysis of 240 febrile episodes. Med Oncol 17 (2000) 111-116
8. Engel A., Knoll S., Kern P., and Kern W.V. Interleukin-8 serum levels at fever onset in patients with neutropenia predict early medical complications. Infection 33 (2005) 380-382
9. Oude Nijhuis C., Kamps W.A., Daenen S.M., et al. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol 23 (2005) 7437-7444
10. Sleijfer D.T., Mulder N.H., de Vries-Hospers H.G., et al. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer 16 (1980) 859-869
11. Oude Nijhuis C.S., Vellenga E., Daenen S.M., et al. Endothelial cells are main producers of interleukin 8 through Toll-like receptor 2 and 4 signaling during bacterial infection in leukopenic cancer patients. Clin Diagn Lab Immunol 10 (2003) 558-563
12. Engel A., Mack E., Kern P., and Kern W.V. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection 26 (1998) 213-221
13. Lehrnbecher T., Venzon D., de Haas M., et al. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clin Infect Dis 29 (1999) 414-419